JAG Shaw Baker’s strategic commercial and corporate legal practice is focused on the life sciences, clean tech and digital technology markets.
We specialise in UK, US and European corporate finance, investment, M&A, intellectual property, commercial contracts, due diligence and general counsel matters for every stage of a company’s life.
Our UK and US trained lawyers provide practical business guidance and collaborative advice to entrepreneurs, companies and investors in their business transactions and relationships with commercial and corporate partners. JAG Shaw Baker is also a gateway to Europe for US entrepreneurs and global VC investors.
Ad Clearance / Branding & Trade Mark Protection / Capital Markets / Commercial Contracts / Copyrights / Corporate Governance & Shareholder Issues / Debt & Equity / Due Diligence / Formations & Company Administration / Financial Transactions / General Counsel / Intellectual Property / Investment Funds / Intellectual Property Disputes / Life Sciences Licensing / M&A and Exits / Privacy & Data Protection / Private Equity / Shareholder Agreements / Structuring & Restructuring / Technology Transactions / Terms & Conditions / Venture Capital
Digital Media & Entertainment / Clean Technology / Computer Hardware & Software / e-Commerce / Education Technology / Fashion Technology / Financial Technology / Internet & Social Investment Funds / Life Sciences, healthcare & biotech / Media / Media & New Media / Medical Devices / Venture Capital
Helping innovative drugs and therapies go to market.
We have one of the most renowned life sciences practices in the UK. We help companies commercialise technology and scientific discoveries. Our life sciences practice helps companies bring more innovative drugs, therapies and devices to the market which helps people live longer and healthier lives.
We have solid experience in helping companies develop, test and commercialise pharmaceutical products through their entire life cycle. We help companies invest and commercialise in technology and scientific discoveries.
Our clients include pharmaceuticals, biotechs, medical devices and healthcare companies.
Specific areas of focus include:
Confidentiality agreements and term sheets
Material transfer agreements
Clinical trial agreements with CROs, institutions and investigators
Master services agreements
Co-promotion and co-marketing agreements
Licences and option agreements
Research collaboration and joint venture agreements
Manufacturing, supply and distribution agreements
Advice on compliance issues, including in relation to the ABPI code, clinical trial regulation, study advertisements and clinical trial compensation guidelines
Outsourced General Counsel to a number of life sciences companies including leading oncology company on all legal matters including pre-clinical trials and phase 3 clinical trials.
Advised on phase 3 clinical trial negotiation and contract management for four major biotech companies.
Negotiated clinical trial agreements for clients in more than 40 countries.
Advised UK-based company on a co-development agreement with US multinational for the development and approval of a leukaemia drug.
Advisers to early stage biotech and life sciences companies on regulatory compliance and IP portfolio acquisitions.
Advised founders on spin-out from Cambridge University and advised several biotech companies on significant fundraising rounds to support their drug development programmes.
Adviser to several life sciences venture capital fund investors on equity investments.
We provide unparalleled insight into the finer details of acquisition and international expansion.
Our corporate team has a unique set of legal expertise to meet the business nuances of investors, VCs and high-growth companies.
And, no matter what name the UK startup market goes by – Tech City, Silicon Roundabout, Silicon Allee, Cambridge Cluster, or the Manchester Tech scene – JAG Shaw Baker’s practice is always centered on supporting the UK and European technology market with strategic legal advice and business guidance through every stage of a company’s lifecycle.
We work with key contributors and stakeholders in the European tech community including start-ups and incubators, multinational enterprises and government organizations.
We also partner with leading European VC firms and accelerators to advise investors on the best path to take to protect those investments and help build the business through to a successful exit.
JAG Shaw Baker has worked with more than 200 digital technology companies on seed, Series A-E, M&A and IPO transactions.
Our venture capital team advised on more than 180 transactions in 2015 and more than 46 investor-side financings in 2015.
We represented more than 130 company-side financing matters in 2015 and more than 88 venture and growth investors.
We are advisers to the BVCA drafting committee for Model Series A documents as well as number of VCs preparing model form equity documents.
We drafted UKISS and ASA documents to create a standardized framework for UK startups for leading accelerators including Seedsummit, Seedcamp and 500 Startups.
Represented a major syndicate of VCs on pre-IPO reorganization of the sale preference prior to the IPO.
Representing five VC/PE-backed companies on exit strategies with independently assessed values of in excess of $4 billion.
Helping clients protect their IP, brand & investment for expansion and growth.
We have one of the strongest intellectual property (IP) and brand protection practices in the UK. Our specialised team advises on the commercialisation, exploitation and enforcement of IP rights, covering contentious and non-contentious issues relating to patents, trade marks, copyright and other IP rights.
From advising a children’s e-publishing business on various prize competitions including sending the winner’s book to be read on the International Space Station to anti-counterfeiting support for a global financial services provider in Europe, US, China and Australia, our IP practice helps high-growth companies protect their investment so they can expand without worry and focus on their business.
We are specialists in these areas:
Negotiating and drafting licensing and commercial agreements
National and international collaborations
Research and development arrangements
Data protection and privacy strategy
IP protection and strategies
Brand and trade mark protection
Negotiated various licensing and IP agreements with governmental and academic research institutions worldwide, including Cuba.
Advisors to a 3D mapping technology business on interior 3D mapping for public arenas and event spaces.
Ongoing advisers to life sciences and corporate clients on anti-cybersquatting, anti-piracy programs and EU privacy regulations.
Won a successful appeal to the Independent Reviewer of ASA adjudications against high profile disruptive advertising.
Worldwide brand protection for a number of clients including a global digital music technology business.
Advised a UK-based telecommunications provider on contractual claims against a global telco business and their rights in relation to telecommunications regulator.
Advisers on licence arrangements with parties in the US, Europe and Japan for multinational print technology business.
Advising life sciences businesses on clinical trial arrangements and IP licensing in multiple jurisdictions.
London / JAG Shaw Baker / Berners House / 47-48 Berners Street / W1T 3NF
Edinburgh / JAG Shaw Baker / 14-18 Hill Street / Edinburgh / EH2 3JZ
Tel: +44 203 598 3070 / Email: firstname.lastname@example.org
A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information
A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree.
We use the following cookies:
• Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page.
• Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB.
The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime.
You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website.